You are here: Industry Insights > Drug development

News List

How to Choose a Small-molecule Drug Substance Partner Saher Haider
August 02, 2024
In this article, we will specifically focus on criteria for selecting a small-molecule drug substance partner.
New Drugs for Old: Repurposing and Repositioning Pharmaceuticals Suzanne Elvidge
July 15, 2024
Drug repurposing and repositioning offers a cost effective and efficient route to the market that allows patients to get access to drugs more quickly.
Vetter Wins Best Managed Companies Award 2024 PharmaSources
May 30, 2024
Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has once again been awarded the Best Managed Companies Award, marking its fifth consecutive win.
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards PharmaSources
March 27, 2024
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
How could AI change drug development by ChatGPT PharmaSources
February 26, 2024
Artificial Intelligence (AI) has the potential to significantly impact and revolutionize the field of drug development in several ways.
Overview of New "Don't Eat Me" Target CD24 Research Zhaoruijie/PharmaSources
July 03, 2023
Recently, Antengene Corporation announced that the Phase I clinical trial application (IND) of its global first anti-CD24 monoclonal antibody, ATG-031, had been approved by FDA.
Development of Anticancer Drugs for Ferroptosis: An Analysis of Representative Natural Products PharmaSources/Yuntian
May 08, 2021
Over the past years, anticancer strategies based on ferroptosis have been well acknowledged, leading to a boom in the development of anticancer drugs at home and abroad.
Alternative Method to Accelerate Drug Development Lin Zhang
January 21, 2021
Drug development is an essential process in the pharmaceutical industry, however, it is also time-consuming and costly which contains preclinical, clinical and after-market.
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.
Advantages to Using CROs Lin Zhang
November 12, 2020
Today, contract research organizations (CROs) provide crucial services for almost any point along the drug pipeline.

Previous page 1 2 3 4 5 6 Next page